# Inogen, Inc. (INGN)

> Source: Nexqual · https://nexqual.com/INGN · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Inogen, Inc. (INGN), nexqual.com/INGN" · informational, not investment advice.

**Price:** USD 6.3 (+2.69% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 6.13 · day 6.2–6.37 · 52w 5.05–9.13 · market cap $167M · NMS

## Key facts
- Analysts: Buy (mean 1.50 on a 1–5 scale) (2 analysts), mean target USD 12 (range 12–12).
- Total return with dividends: 1Y -26.0% vs S&P 500 +18.1%; 5Y -84.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.06, revenue estimate $92.3M.

## Analysts
Consensus Buy (mean 1.50 on a 1–5 scale), 2 analysts; mean target USD 12 (low 12, high 12).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -26.0% | -84.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -26.1% | -31.1% |
| Volatility (annualized) | 44.0% | 59.3% |
| Max drawdown | -43.1% (Oct 2025→Sep 2026) | -89.8% (Oct 2021→Oct 2023) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/INGN · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt